Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study

By sjmartinez • November 14, 2024

Berg JI, Nielsen SM, Malm E, Ioannidis JPA, Furst DE, Smolen JS, Taylor PC, Kristensen LE, Tarp S, Ellingsen T, Christensen R. Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study. Ann Rheum Dis. 2024 Nov 8:ard-2024-226129. doi: 10.1136/ard-2024-226129. Epub ahead of print. PMID: 39521451.

Tags: Arthritis, Axial Spondyloarthritis, biological therapy, Epidemiology, Psoriatic, Publications, Rheumatoid, Rheumatology

Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead

Tang AB, Lewsey SC, Yancy CW, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Thomas K, Fonarow GC. Get[...]

Worsening Racial and Ethnic Disparities in Colorectal Cancer Screening Rates in United States Federally Qualified Health Centers

Zhao MY, Aaronson MRM, Singh V, De Silva SR, Badiee J, May FP. Worsening Racial and Ethnic Disparities in Colorectal Cancer Screening Rates in United[...]

Validating the Sino-Nasal Outcome Test (SNOT-22) in comparison to the Sino-Nasal 5 Questionnaire (SN-5) in a pediatric population

Cheng MY, Rodriguez DR, Rubio A, Jackson NJ, West AN. Validating the Sino-Nasal Outcome Test (SNOT-22) in comparison to the Sino-Nasal 5 Questionnaire (SN-5) in[...]